Tontsch-Grunt, Ulrike <br/><br/>
Synergistic activity of BET inhibitor BI 894999 with PLK inhibitor volasertib in AML in vitro and in vivo.  [electronic resource] 

 -  Cancer letters  05 2018 
 - 112-120 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2018.02.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzene Derivatives--pharmacology<br/>Cell Line<br/>Drug Synergism<br/>Genes, myc<br/>Humans<br/>Leukemia, Myeloid, Acute--genetics<br/>Mice<br/>Protein Kinase Inhibitors--pharmacology<br/>Proteins--antagonists & inhibitors<br/>Pteridines--pharmacology